← Back to screener

CSX CORP CSX

Rank #941 · Nasdaq · $96.6B market cap
Audited by Ernst & Young LLP, no going-concern flag in the latest filing.
Score
55.8
P/E
26.3
P/B
7.75
ROE
29.4%
Op. Margin
37.5%
Debt Ratio
243%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★★☆☆☆
Average

P/E 26.3x, P/B 7.75x. Ranks in the top 56% of the universe.

Profitability ★★★★☆
Excellent

ROE 29.4%. Ranks in the top 10% of the universe.

Safety ★★☆☆☆
Weak

Debt ratio 243%. Ranks in the top 67% of the universe. Above 200% signals meaningful leverage risk.

Growth ★★☆☆☆
Weak

Revenue decline of 1.3% year over year. Ranks in the top 68% of the universe.

Profitability is the relative strength · Valuation is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2011–$2.3B$1.1B$8.0B–243
2012–$3.1B$1.6B$8.8B–238
2013–$3.5B$1.9B$8.8B–237
2014–$3.5B$1.9B$8.6B–247
2015–$3.5B$1.9B$9.1B–239
2016–$3.6B$1.9B$10.5B–220
2017–$3.6B$2.0B$11.2B–212
2018$11.1B$3.4B$1.7B$11.7B30.8180
2019$11.4B$3.7B$5.5B$11.7B32.6207
2020$12.2B$4.9B$3.3B$14.7B39.7179
2021$11.9B$5.0B$3.3B$12.6B41.6212
2022$10.6B$4.4B$2.8B$11.9B41.2228
2023$12.5B$5.6B$3.8B$13.1B44.7223
2024$14.9B$6.0B$4.1B$13.5B40.1217
2025$14.7B$5.5B$3.7B$12.5B37.5243

← See the full screener